Works matching IS 09024441 AND DT 2023 AND VI 110 AND IP 2
Results: 17
High expression of AP2M1 correlates with worse prognosis by regulating immune microenvironment and drug resistance to R‐CHOP in diffuse large B cell lymphoma.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 198, doi. 10.1111/ejh.13895
- By:
- Publication type:
- Article
Efficacy of venetoclax plus anti‐CD38 monoclonal antibody‐containing therapies among t(11;14) positive multiple myeloma patients regardless of timing of prior treatment with this antibody.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 222, doi. 10.1111/ejh.13896
- By:
- Publication type:
- Article
Clearance of bone marrow mast cells after hypomethylating agent and venetoclax for systemic mastocytosis associated with myeloid neoplasia.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 213, doi. 10.1111/ejh.13894
- By:
- Publication type:
- Article
Individualized busulfan dosing improves outcomes compared to fixed‐dose administration in pre‐transplant minimal residual disease‐positive acute myeloid leukemia patients with intermediate‐risk undergoing allogeneic stem cell transplantation in CR
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 188, doi. 10.1111/ejh.13893
- By:
- Publication type:
- Article
The role of oral iron in the treatment of adults with iron deficiency.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 123, doi. 10.1111/ejh.13892
- By:
- Publication type:
- Article
Outcomes of coronavirus disease 2019 (COVID‐19) and risk factors associated with severe COVID‐19 in patients with mature B‐cell non‐Hodgkin lymphomas: A US electronic health record cohort study.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 177, doi. 10.1111/ejh.13891
- By:
- Publication type:
- Article
Real‐world utility of early measurable residual disease assessments by multi‐parametric flow cytometry in adult patients with B‐lymphoblastic leukemia receiving Hyper‐CVAD induction chemotherapy.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 168, doi. 10.1111/ejh.13890
- By:
- Publication type:
- Article
Management of polycythemia vera: A survey of treatment patterns in Italy.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 161, doi. 10.1111/ejh.13889
- By:
- Publication type:
- Article
Response to "Conditioning with melphalan (Mel) 200 mg/m<sup>2</sup> and subsequent autologous stem cell transplantation improves progression free survival and overall survival in elderly multiple myeloma patients compared to standard of care".
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 221, doi. 10.1111/ejh.13888
- By:
- Publication type:
- Article
Phenotype of BTK‐lacking myeloid cells during prolonged COVID‐19 and upon convalescent plasma.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 209, doi. 10.1111/ejh.13881
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 121, doi. 10.1111/ejh.13792
- Publication type:
- Article
Response to Caravita di Toritto and Rago.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 224, doi. 10.1111/ejh.13887
- By:
- Publication type:
- Article
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission—A retrospective multicenter study.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 149, doi. 10.1111/ejh.13884
- By:
- Publication type:
- Article
Cytogenetic and molecular characteristics and outcomes of adult patients with early T‐cell precursor acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 137, doi. 10.1111/ejh.13883
- By:
- Publication type:
- Article
Non‐driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 131, doi. 10.1111/ejh.13882
- By:
- Publication type:
- Article
Preemptive cyclosporin A in immune‐mediated thrombotic thrombocytopenic purpura.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 157, doi. 10.1111/ejh.13886
- By:
- Publication type:
- Article
IDH2<sup>R172</sup> mutation in angioimmunoblastic T‐cell lymphoma: A retrospective multicenter case series.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 217, doi. 10.1111/ejh.13885
- By:
- Publication type:
- Article